Downregulation of decorin and transforming growth factor-β1 by decorin gene suppression in tendinocytes

Connective Tissue Research

Volumn 46, Issue 1, 2005, Pages 18-26

  Hosaka, Yoshinao ^a   Kirisawa, Rikio ^a   Mafune, Naoki ^a   Takehana, Kazushige ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

Antisense oligodeoxynucleotides; Decorin; Scar; Tendinocytes; Transforming growth factor (TGF) 1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DECORIN; TRANSFORMING GROWTH FACTOR BETA1; COMPLEMENTARY DNA; MESSENGER RNA; OLIGODEOXYRIBONUCLEOTIDE; PROTEOGLYCAN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACHILLES TENDON; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONNECTIVE TISSUE CELL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSFECTION; MALE; NEW ZEALAND; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SCAR FORMATION; TENDINOCYTE; ANIMAL; BIOSYNTHESIS; CELL CULTURE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; TENDON;

ORYCTOLAGUS CUNICULUS;

ANIMALS; CELLS, CULTURED; DNA, COMPLEMENTARY; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; OLIGODEOXYRIBONUCLEOTIDES; PROTEOGLYCANS; RABBITS; RNA, MESSENGER; TENDONS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 20444473781     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200590935510     Document Type: Article

References (44)

1. Jozsa, L.G., and Kannus, P. (1997). Human tendons. In Anatomy, Physiology and Pathology, L.G. Jozsa and P. Kannus (eds.), pp. 76-81. (Human Kinetics, Champaign, IL).
2. Oikawa, M., and Kasashima, Y. (2002). The Japanese experience with tendonitis in racehorses. J. Equine Sci. 13:41-56.
3. Frank, C., McDonald, D., Wilson, J., Erye, D., and Schrive, N. (1995). Rabbit medical collateral ligament scar weakness is associated with decreased collagen pyridinoline crosslink density. J. Orthop. Res. 13:157-165.
4. Eriksen, H.A., Pajala, A., Leppilahti, J., and Risteli, J. (2002). Increased content of type III collagen at the rupture site of human Achilles tendon. J. Orthop. Res. 20:1352-1357.
5. Shimomura, T., Jia, F., Niyibizi, C., and Woo, S.L. (2003). Antisense oligonucleotides reduce synthesis of procollagen alpha1 (V) chain in human patellar tendon fibroblasts: potential application in healing ligaments and tendons. Connect. Tissue Res. 44:167-172.
6. Frank, C., McDonald, D., and Schrive, N. (1997). Collagen fibril diameters in the rabbit medial collateral ligament scar: A long term assessment. Connect. Tissue Res. 36:261-269.
7. Magnusson, S.P., Qvortrup, K., Larsen, J.O., Rosager, S., Hanson, P., Aagaard, P., Krogsgaard, M., and Kjaer, M. (2002). Collagen fibril size and crimp morphology in ruptured and intact Achilles tendons. Matrix Biol. 21:369-377.
8. Yamamoto, E., Hata, D., Kobayashi, A., Ueda, H., Tangkawattana, P., Oikawa, M., and Takehana, K. (2002). Effect of beta-aminopropionitrile and hyaluronic acid on repair of collagenase-induced injury of the rabbit Achilles tendon. J. Comp. Pathol. 126:161-170.
9. Kuwaba, K., Kobayashi, M., Nomura, Y., Irie, S., and Koyama, Y. (2002). Size control of decorin dermatan sulfate during remodeling of collagen fibrils in healing skin. J. Dermatol. Sci. 29:185-194.
10. Kobayashi, A., Sugisaka, M., Takehana, K., Yamaguchi, M., Eerdunchaolu, Iwasa, E.K., and Abe, M. (1999). Morphological and histochemical analysis of a case of superficial digital flexor tendon injury in the horse. J. Comp. Pathol. 120:403-414.
11. Doillon, C.J., Dunn, M.G., Bender, E., and Silver, F.H. (1985). Collagen fiber formation in repair tissue: Development of strength and toughness. Coll. Relat. Res. 5:481-492.
12. Christiansen, D.L., Huang, E.K., and Silver, F.H. (2000). Assembly of type I collagen: Fusion of fibril subunits and the influence of fibril diameter on mechanical properties. Matrix Biol. 19:409-420.
13. Battaglia, T.C., Clark, R.T., Chhabra, A., Gaschen, V., Hunziker, E.B., and Mikic, B. (2003). Ultrastructural determinants of murine achilles tendon strength during healing. Connect. Tissue Res. 44:218-224.
14. Birch, H.L., Bailey, A.J., and Goodship, A.E. (1998). Macroscopic 'degeneration' of equine superficial digital flexor tendon is accompanied by a change in extracellular matrix composition. Equine Vet. J. 30:534-539.
15. Chakravarti, S., Magnuson, T., Lass, J.H., Jepsen, K.J., LaMantia, C., and Carroll, H. (1998). Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican. J. Cell Biol. 141:1277-1286.
16. Ezura, Y., Chakravarti, S., Oldberg, A., Chervoneva, I., and Birk, D.E. (2000). Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell Biol. 151:779-788.
17. Neame, P.J., Kay, C.J., McQuillan, D.J., Beales, M.P., and Hassell, J.R. (2000). Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell Mol. Life Sci. 57:859-863.
18. Reed, C.C., and Iozzo, R.V. (2000). The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj. J. 19:249-255.
19. Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., and Iozzo, R.V. (1997). Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol. 136:729-743.
20. Corsi, A., Xu, T., Chen, X.D., Boyde, A., Liang, J., Mankani, M., Sommer, B., Iozzo, R.V., Eichstetter, I., Robey, P.G., Bianco, P., and Young, M.F. (2002). Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Miner. Res. 17:1180-1189.
21. Kozma, E.M., Olczyk, K., Glowacki, A., and Bobinski, R. (2000). An accumulation of proteoglycans in scarred fascia. Mol. Cell Biochem. 203:103-112.
22. Nakamura, N., Hart, D.A., Boorman, R.S., Kaneda, Y., Shrive, N.G., Marchuk, L.L., Shino, K., Ochi, T., and Frank, C.B. (2000). Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen fibrillogenesis in vivo. J. Orthop. Res. 18:517-523.
23. Moustakas, A., Pardali, K., Gaal, A., and Helden, C.H. (2002). Mechanisms of TGF-b signaling in regulation of cell growth and differentiation. Immunol. Lett. 82:85-91.
24. Comalada, M., Cardo, M., Xaus, J., Valledor, A.F., Lloberas, J., Ventura, F., and Celada, A. (2003). Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J. Immunol. 170:450-456.
25. Rapraeger, A.C., Krufka, A., and Olwin, B.B. (1991). Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708.
26. Border, K., Liszio, C., Blumberg, P., Schonherr, E., and Kresse, H. (1992). Natural inhibitor of transforming growth factor-b protects against scarring in experimental kidney disease. Nature 360:361-364.
27. Olwin, B.B., and Rapraeger, A. (1992). Repression of myogenic differentiation by aFGF, bFGE and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118:631-639.
28. Aoki, M., Morishita, R., Higaki, J., Moriguchi, A., Kida, I., Hayashi, S., Matsushita, H., Kaneda, Y., and Ogihara, T. (1997). In vivo transfer efficiency of antisense oligonucleotides into the myocardium using. HJV-liposome method. Biochem. Biophys. Res. Commun. 231:540-545.
29. Imai, E., Isaka, Y., Akagi, Y., Kaneda, Y., and Hori, M. (1998). Gene transfer and kidney disease. J. Nephrol. 11:16-19.
30. Simile, M.M., De Miglio, M.R., Muroni, M.R., Frau, M., Asara, G., Serra, S., Muntoni, M.D., Seddaiu, M.A., Daino, L., Feo, F., and Pascale, R.M. (2004). Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25:333-341.
31. Kato, K., Nakanishi, M., Kaneda, Y., Uchida, T., and Okada, Y. (1991). Expression of hepatitis B virus surface antigen in adult rat liver: Cointroduction of DNA and nuclear protein by a simplified liposome method. J. Biol. Chem. 266:3361-3364.
32. Okada, Y. (1993). Sendai virus-induced cell fusion. Methods Enzymol. 221:18-41.
33. Hangai, M., Kaneda, Y., Tanihara, H., and Honda, Y. (1996). In vivo gene transfer into the retina mediated by a novel liposome system. Invest. Ophthalmol. Vis. Sci. 37:2678-2685.
34. Hildebrand, A., Romaris, M., Rasmussen, L.M., Heinegard, D., Twardzik, D.R., Border, W.A., and Ruoslahti, E. (1994). Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 302:527-534.
35. Takeuchi, Y., Kodama, Y., and Matsumoto, T. (1994). Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. J. Biol. Chem. 269:32634-32638.
36. Schmidt, G., Robenek, H., Harrach, B., Glossl, J., Nolte, V., Hormann, H., Richter, H., and Kresse, H. (1987). Interaction of the small dermatan sulfate proteoglycans from fibroblasts with fibronectin. J. Cell Biol. 104:1683-1691.
37. Bindanset, D.J., LeBaron, R., Rosenberg, L., Murphy-Ullrich, J.E., and Hook, M. (1992). Regulation of cell substrate adhesion: Effects of small galactosaminoglycan-containing proteoglycans. J. Cell Biol. 118:1523-1531.
38. Winnemoller, M., Schon, P., Vischer, P., and Kresse, H. (1902). Interactions between thrombospondin and signal proteoglycan decorin: Interferes with cell attachment. Eur. J. Cell. Biol. 59:47-55.
39. Crawford, S. E., Stellmach, V., Murphy-Ullrich, J.E., Ribeiro, S.M., Lawler, J., Hynes, R.O., Boivin, G.P., and Bouck, N. (1998). Thrombospondin-1 is a major activator of TGF-beta 1 in vivo. Cell 93:1159-1170.
40. Lawler, J., Sunday, M., Thibert, V., Duquette, M., George, E.L., Rayburn, H., and Hynes, R.O. (1998). Thrombospondin-1 is required for normal marine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101:982-992.
41. Chen, H., Henderson, M.E., and Lawler, J. (2002). The cell biology of thrombospondin-1. Matrix Biol. 19:597-614.
42. Border, W.A., and Noble, N.A. (1997). TGF-b in kidney fibrosis: a target for gene therapy. Kidney Int. 51:1388-1396.
43. Zhang, K., and Phan, S.H. (1996). Cytokines and pulmonary fibrosis. Biol. Signals 5:232-239.
44. Grainger, D.J., Kemp, P.R., Liu, A.C., Lawn, R.M., and Metcalfe, J.C. (1994). Activation of transforming growth factor-b is inhibited in transgenic apolipoprotein(a) mice. Nature 370:460-462.